Novartis appoints Alessandra Dorigo as General Manager
June 30, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Alessandra Dorigo has been appointed as the new General Manager UK, Ireland, Baltics, and Nordics for Novartis Advanced Accelerator Applications …
Exploring the potential of drug repurposing
June 30, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug repurposing
Drug repurposing is a little like recycling. It is the process of finding new therapeutic uses for drugs that already …
“Worst drug approval decision in recent US history”
June 30, 2021Research and Development
The FDA’s decision to accelerate approval for Aduhelm, the first new drug for Alzheimer’s in two decades, has been met …
Sickle cell therapy granted innovation passport by MHRA
June 30, 2021Research and Development MHRA, SCD, brexit
Bluebird bio has been granted an innovation passport, under the new UK approval process, for LentiGlobin (bb1111) a promising treatment …
EU approves BMS’s treatment for metastatic colorectal cancer
June 30, 2021Research and Development
The EU has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) for the treatment of metastatic colorectal cancer. The treatment will be …
RNA breakthrough: Fluorescence used to track molecule movement
June 30, 2021Research and Development AstraZeneca, RNA, mrna
Researchers at Chalmers University of Technology in Sweden have announced a breakthrough in the labelling method of messenger RNA (mRNA) …
EU approves Merck’s treatment for oesophageal cancer
June 30, 2021Research and Development
The EU has approved Merck’s KEYTRUDA, in combination with platinum- and fluoropyrimidine-based chemotherapy, as treatment for advanced oesophageal cancer. The …
Next generation organ-on-a-chip technology adopted by King’s College London
June 29, 2021Manufacturing and Production organ-on-a-chip, research collaboration, technology, university
CN Bio, an organ-on-a-chip company that designs and manufactures single and multi-organ microphysiological systems (MPS), has announced that their novel …
CHMP issue positive opinion for Incyte and MorphoSys’ tafasitamab
June 29, 2021Manufacturing and Production CHMP, EMA, EU, FDA, US
Incyte and MorphoSys have announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive …
Quantoom & eTheRNA to collaborate on revolutionary RNA production system
June 29, 2021Manufacturing and Production RNA, collaboration
Quantoom and eTheRNA immunotherapies have announced a strategic collaboration to develop a revolutionary RNA production system (RPS) for both research …
NICE recommends that all women should do pelvic floor exercises
June 29, 2021Manufacturing and Production NHS, NICE, pelvic floor, women's health
NICE has recommended in draft guidance that girls as young as 12 should be encouraged to do pelvic floor muscle …
Avacta’s lateral flow test can detect Delta variant
June 29, 2021Manufacturing and Production Avacta, COVID-19, Delta variant, antigen lateral flow test
A study has shown that Avacta’s AffiDX antigen lateral flow test can detect the Delta variant of COVID-19. The test …
Astellas receives positive CHMP opinion for symptomatic anaemia drug
June 28, 2021Sales and Marketing Astellas, CKD, anaemia
Astellas and FibroGen have announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMA has adopted …
Samsung Bioepis & Biogen receive positive CHMP opinion for ranibizumab biosimilar
June 28, 2021Sales and Marketing EC, EMA, EU, biosimilars
Samsung Bioepis and Biogen have announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) has adopted a …
Eli Lilly’s Type 2 diabetes drug outperforms semaglutide in trials
June 28, 2021Sales and Marketing Eli Lilly, semaglutide, type 2 diabetes
Eli Lilly has announced that the SURPASS-2 clinical trial has shown tirzepatide achieved superior HbA1C and body weight reductions compared …
Polyphor’s future in question after co-primary endpoint in breast cancer study missed
June 28, 2021Sales and Marketing Primary Endpoint, breast cancer
Swiss biopharmaceutical company, Polyphor, has announced that its global Phase III study, FORTRESS, evaluating balixafortide (POL6326) in combination with eribulin …
Medical cannabis formulation kills breast cancer cells in trial
June 28, 2021Sales and Marketing breast cancer, medical cannabis, oncology
UK-based pharma company, Apollon Formularies, have announced that their medical cannabis formulations were successful in killing triple-negative breast cancer (TNBC) …
Tapeworm drug to be trialled nationally as COVID treatment
June 25, 2021Medical Communications COVID-19, NHS, dialysis, kindey, tapeworm
Kidney patients in Bristol are being offered a clinical trial to see whether a drug used for tapeworm patients can …
Eli Lilly to seek FDA approval for experimental Alzheimer’s drug
June 25, 2021Medical Communications Alzheimer's, Eli Lilly, FDA
Eli Lilly plans to seek accelerated FDA approval for its experimental Alzheimer’s drug donanemab, announcing plans on Thursday to file …
Exscientia to collaborate with EQRx on drug development
June 25, 2021Medical Communications AI, Exscientia, clinical drug development
Exscientia and EQRx have announced a strategic research and development collaboration agreement aiming to substantially accelerate the delivery of novel …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
